Plain-English translation of NCT06864221 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying special molecules in your blood called sphingolipids to see if they can predict how well radiation therapy will work for your liver cancer. By collecting blood samples before, during, and after your radiation treatment, the study team hopes to find early signs of whether the therapy is helping your body fight the cancer.
Current methods of checking if radiation therapy is working require waiting weeks or months for imaging scans, which delays important treatment decisions. This study exists to find blood-based markers that could show treatment success much earlier, and to help doctors predict which patients might experience serious side effects so they can adjust care accordingly.
You likely qualify if…
You likely don't qualify if…
You will receive your standard radiation therapy as planned by your doctor. During the study, you will have blood samples taken before your radiation starts, at points during your treatment, and after it ends. The research team will follow your progress for two years, tracking how well the radiation worked using routine imaging scans and blood tests you'd normally receive anyway, plus analyzing your blood samples for those special molecules to see if they predicted your response.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
China